Table 1 Demographic and clinical characteristics of patients at intake.
From: Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
Total (188) | |
|---|---|
Mean age (SD) | 12.9 (7.0) |
Gender (male), No. (%) | 154 (81.9) |
Mean body mass index (SD) | 29.0 (5.3) |
Previous experience with cannabis (Yes), No. (%) | 19 (10.1) |
Comorbidities: | |
Epilepsy, No. (%) | 27 (14.4) |
Attention Deficit Hyperactivity Disorder, No. (%) | 7 (3.7) |
Tourette syndrome, No. (%) | 4 (2.1) |
Celiac Disease, No. (%) | 3 (1.6) |
Anxiety Disorder, No. (%) | 3 (1.6) |
